News

Our news cover the latest topics from the past 30 days, as retrieved from Japanese-language press releases and other information sources.

For older news topics, please use the archive button.

Please use the search module to retrieve information on institutes, researchers and research topics

 

 

Tanabe Mitsubishi turns product development over to venture company

Mitsubishi Tanabe announced that phase I of its antibody-drug complex MT-8633 against solid cancer will be carried out by Open Innovation Partners, a Tokyo-based venture. It is believed that this move is meant to raise development speed.

Tanabe-Mitsubishi Pharma news release, February 14, 2019